AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34392146
Drug: Dose-response relationship
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose-response relationship of anthocyanins
Trial: 36808239
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg/d
Trial: 33899649
Drug: MET 1000
RxNorm normalized name: Fortamet 1000mg Extended-Release Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MET 1000 mg alone
Trial: 33899649
Drug: FOT 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOT 24 mg and MET
Trial: 33899649
Drug: FOT 24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOT 24 mg alone
Trial: 35158205
Drug: Durvalumab (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Durvalumab (20 mg/kg/i.v. every 4 weeks for 12 months)
Trial: 33693703
Drug: Transdermal 17-beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17-beta estradiol 0.1 mg/day with 30 mcg/kg/dose of rhIGF-1 administered subcutaneously twice daily (AN-IGF-1+)
Trial: 33693703
Drug: Transdermal 17-beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17-beta estradiol 0.1 mg/day with placebo (AN-IGF-1-)
Trial: 33487271
Drug: Probiotic (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic (500 mg)
Trial: 39764100
Drug: Intensity-modulated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensity-modulated radiation therapy (IMRT)
Trial: 34258785
Drug: k-resolution sequential
RxNorm normalized name: Effer-K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: k-resolution sequential randomization (k-RSR) procedure
Trial: 34258785
Drug: pairwise sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pairwise sequential randomization (PSR) procedure
Trial: 34006077
Drug: Photofunctionalised implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photofunctionalised implant
Trial: 34006077
Drug: Untreated implant
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Untreated implant (control group)
Trial: 32156838
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline plus N‐acetylcysteine (1200mg twice a day for 2 days) (Group B)
Trial: 33217362
Drug: High-dose CoronaVac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose CoronaVac (6 μg per 0.5 mL)
Trial: 37379158
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (control group)
Trial: 37232538
Drug: Urotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urotherapy and parasacral TENS (20 sessions, 3 times weekly, 20 min each, 10 Hz frequency, 700 μS pulse width)
Trial: 34260454
Drug: 2.5 IU
RxNorm normalized name: Rabies Vaccine 2.5 IU/1 ML Injection Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 IU Botulinum Toxin (BT) injection at 1 point per side (2‐points group)
Trial: 34260454
Drug: 5 IU
RxNorm normalized name: Vitamin E 15 IU/0.3 ML Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 IU Botulinum Toxin (BT) injection at 2 points per side (4‐points group)
Trial: 33807285
Drug: Intervention aimed
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention aimed at improving information on cardiovascular risk; details on dosage and duration not specified
Trial: 33008479
Drug: Kampo medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kampo medicine (kakkonto and shosaikotokakikyosekko) administered 2.5 g of KT and 2.5 g of SSKKS three times a day for 14 days in addition to conventional treatment.
Trial: 33008479
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with antipyretics, painkillers, or antitussives.
Trial: 32675606
Drug: Exercise therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise therapy (Xinmiao treatment system, >3 days/week, >1 h/day)
Trial: 616663253
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of classroom and simulation-based courses
Trial: 32651298
Drug: Oral factor
RxNorm normalized name: intrinsic factor Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral factor Xa inhibitors (combined analysis)
Trial: 33385624
Drug: Standard-dose protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose protocol (120 kV, 100 mA)
Trial: 33385624
Drug: Ultra-low-dose protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultra-low-dose protocol (80 kV, 10 mA)
Trial: 33611671
Drug: Daily ultra-low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily ultra-low-dose prednisolone
Trial: 33045334
Drug: 650 mg
RxNorm normalized name: bran 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 650 mg acetaminophen every 6 hours for pain, with 5 mg/325 mg oxycodone-acetaminophen for breakthrough pain
Trial: 33045334
Drug: 5 mg/325
RxNorm normalized name: Xartemis XR 7.5 MG/325 MG 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/325 mg oxycodone-acetaminophen prescribed as 1 to 2 tablets every 6 hours as needed for pain (standard of care)
Trial: 34144529
Drug: Withania somnifera
RxNorm normalized name: WITHANIA SOMNIFERA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withania somnifera (Ashwagandha) 6 gm in powder form or extracts in tablets, or 500-1000 mg capsule for 8-12 weeks
Trial: 33878855
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of zinc and arginine (lotion A)
Trial: 33878855
Drug: Placebo (lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lotion B)
Trial: 37660042
Drug: Extracorporeal Shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Shock Wave Therapy (ESWT)
Trial: 36167555
Drug: Anti-pseudomonal antibiotic
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-pseudomonal antibiotic treatment with intravenous beta-lactam and oral ciprofloxacin for 14 days
Trial: 34633418
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (continuous subcutaneous insulin infusion or multiple daily insulin injections with or without CGM)
Trial: 35775453
Drug: Hybrid closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed-loop (HCL) therapy
Trial: 34808697
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant treatment
Trial: 38867220
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM)
Trial: 34265388
Drug: Intra-articular injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular injections of PBSCs plus HA after arthroscopic subchondral drilling
Trial: 32814506
Drug: GLU (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLU (1.2 g·min‐1 dextrose alone)
Trial: 32814506
Drug: GLU+CAL (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLU+CAL (1.2 g·min‐1 dextrose with 2000 mg calcium)
Trial: 35100594
Drug: Tamsulosin HCL
RxNorm normalized name: tamsulosin HCl
DrugBank: Tamsulosin (DB00706)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamsulosin HCL 0.4 mg cap + diclofenac Na 100 mg tab (to be taken only during colic episodes)
Trial: 35100594
Drug: Diclofenac Na
RxNorm normalized name: DICLOFENAC NA 1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac Na 100 mg tab only (to be taken only during colic episodes)
Trial: 36054131
Drug: Dairy milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy milk (DM) - consumed twice daily (30g protein/day)
Trial: 33569814
Drug: Control (monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (monthly paper-based questionnaire)
Trial: 33211921
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement with calcium (200 mg daily), vitamin D3 (600 IU), and vitamin B6 (2 mg) for 12 months in group 1.
Trial: 33211921
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement with calcium (200 mg daily), vitamin D3 (600 IU), and vitamin B6 (2 mg) for 12 months in group 2.
Trial: 33211921
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no dietary supplement) in group 3.
Trial: 32752932
Drug: M207 3.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M207 3.8 mg
Trial: 35902887
Drug: Brolucizumab (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brolucizumab (6 mg/50 µL)
Trial: 35902887
Drug: Aflibercept (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept (2 mg/50 µL)
Trial: 32758299
Drug: nab-paclitaxel 125
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-paclitaxel 125 mg/m2 (arm B)
Trial: 32758299
Drug: nab-paclitaxel 100
RxNorm normalized name: paclitaxel 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nab-paclitaxel 100 mg/m2 (arm A)
Trial: 35867857
Drug: Study group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Study group (n=39) with additional interventions: local anesthetic infiltration, IV dexmedetomidine, IV ketamine, additional IV dexamethasone, and repeated adductor canal block injections
Trial: 35867857
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (n=39) with standard multimodal analgesic regimen
Trial: 33619550
Drug: Pertuzumab plus
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab plus trastuzumab and standard chemotherapy
Trial: 33619550
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus trastuzumab and standard chemotherapy
Trial: 32228427
Drug: Chamomile oil
RxNorm normalized name: chamomile oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chamomile oil inhalation
Trial: 32199656
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 50 mg/kg
Trial: 38388189
Drug: Simvastatin 20
RxNorm normalized name: simvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 20 mg/day
Trial: 33774594
Drug: Methylprednisolone (1g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1g administered intravenously upon induction of anaesthesia)
Trial: 32867852
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) plus standard personal protective equipment (PPE) - 800mg loading dose on day of randomization (two 400mg doses 12 hours apart), followed by 400mg once a week for 12 weeks.
Trial: 33955162
Drug: 105 mg
RxNorm normalized name: menthol 105 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 105 mg edaravone oral suspension
Trial: 32321450
Drug: Sodium bicarbonate,
RxNorm normalized name: Sodium Bicarbonate, 325 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate, Sodium-potassium citrate, Standard therapy
Trial: 36379437
Drug: Alcohol Telemedicine
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol Telemedicine Consult (ATC) Service, including alcohol pharmacotherapy and SBIRT delivered by clinical pharmacists
Trial: 37505258
Drug: Renal replacement
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal replacement therapy (RRT)
Trial: 33066081
Drug: n‐3 PUFA‐enriched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 PUFA‐enriched hen eggs (two eggs per day, for three weeks, total of approximately 407 mg/day n‐3 PUFAs)
Trial: 33066081
Drug: Regular eggs
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular eggs (two eggs per day for three weeks, total of approximately 75 mg/day n‐3 PUFAs)
Trial: 33753956
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg
Trial: 32203892
Drug: CGX 1
RxNorm normalized name: CGX-1321
DrugBank: CGX-1321 (DB17491)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGX 1 g
Trial: 32203892
Drug: CGX 2
RxNorm normalized name: CGX-1321
DrugBank: CGX-1321 (DB17491)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGX 2 g
Trial: 32203892
Drug: CGX 1
RxNorm normalized name: CGX-1321
DrugBank: CGX-1321 (DB17491)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGX 1 g (without antiviral use)
Trial: 39217565
Drug: Semaglutide 2.4
RxNorm normalized name: semaglutide 2.4 MG in 0.75 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide 2.4 mg once weekly
Trial: 35439567
Drug: Semaglutide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide plus cilofexor 30 mg
Trial: 35439567
Drug: Semaglutide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide plus cilofexor 100 mg
Trial: 35439567
Drug: Semaglutide plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide plus firsocostat 20 mg
Trial: 35439567
Drug: Semaglutide, cilofexor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide, cilofexor 30 mg and firsocostat
Trial: 33704466
Drug: OJ with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OJ with 5 g fiber from OP (OPF)
Trial: 33536047
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of IV tranexamic acid (TXA) at admission
Trial: 35112378
Drug: Intravenous tanezumab
RxNorm normalized name: tanezumab
DrugBank: Tanezumab (DB12335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tanezumab (2.5–20 mg every 8 weeks for up to 56 weeks)
Trial: 35112378
Drug: Treatment-emergent anti-drug
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-emergent anti-drug antibodies (TE ADA)
Trial: 33012216
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (PRO; 60 g/day)
Trial: 36477706
Drug: Sugammadex 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex 0.5 mg/kg
Trial: 33268476
Drug: NSAIDs (non-steroidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (non-steroidal anti-inflammatory drugs) as a strong opioid adjunct
Trial: 35889835
Drug: Flaxseed supplementation
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed supplementation (28 g/day) for 10 weeks in group 1 (lean patients with severe dyslipidaemia)
Trial: 35889835
Drug: Flaxseed supplementation
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed supplementation (28 g/day) for 10 weeks in group 2 (obese patients with mild dyslipidaemia)
Trial: 35889835
Drug: Flaxseed supplementation
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed supplementation (28 g/day) for both groups
Trial: 36167574
Drug: Intravenous anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anesthesia with propofol
Trial: 33126873
Drug: Standard Occupational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Occupational Therapy (SOT)
Trial: 33105036
Drug: Ipilimumab 3
RxNorm normalized name: Ipilimumab
DrugBank: Ipilimumab (DB06186)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ipilimumab 3 mg/kg
Trial: 36069480
Drug: Implant Surface
RxNorm normalized name: hepatitis B surface antigen vaccine Injection [Recombivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant Surface Culture (ISC)
Trial: 32699909
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (two cycles of methotrexate, doxorubicin, vinblastine, and cisplatin) followed by radical cystectomy
Trial: 36529052
Drug: Prednisone treatment
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone treatment
Trial: 32274986
Drug: Hollow fiber
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hollow fiber ultrafilter (HFU) distributed to intervention households, used for household water treatment over a 1-year period.
Trial: 616330511
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 0-1-2 month schedule
Trial: 616330511
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (7vPCV) recipients
Trial: 39453837
Drug: Empagliflozin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin (10 mg once daily)
Trial: 33989338
Drug: Walking behavior
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Walking behavior change (daily step count)
Trial: 34951503
Drug: Groupwise Autonomy
RxNorm normalized name: AUTONOMIC MEDICATIONS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Groupwise Autonomy Enhancing Treatment (AET)
Trial: 34951503
Drug: Groupwise Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Groupwise Cognitive Behavioral Therapy (CBT)
Trial: 32387472
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (FOLINORAL®) 5 mg twice daily
Trial: 38862179
Drug: Aspirin monotherapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin monotherapy (100 mg once daily)
Trial: 34989804
Drug: Aflibercept (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept (2.0 mg/0.05 mL)
Trial: 32056817
Drug: Pranayama breathing
RxNorm normalized name: cetylpyridinium chloride Mouthwash [Breath-Away]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pranayama breathing technique for 20 min once daily for 1 month
Trial: 34237184
Drug: Home exercise
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home exercise program (same exercises at home on their own with weekly calls)
Trial: 33307785
Drug: Empagliflozin (10/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empagliflozin (10/25 mg)
Trial: 35641166
Drug: Placebo (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham treatment)
Trial: 34301646
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone (control)
Trial: 33070770
Drug: Betamethasone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (12 mg/kg/BW twice, intramuscularly)
Trial: 32393387
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of 0.125 M l-glutamic acid
Trial: 32393387
Drug: Saline (1.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (1.65 mL/kg of body weight per hour)
Trial: 34562648
Drug: CO2 laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 laser therapy
Trial: 35841189
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose of alcohol (MED)
Trial: 35841189
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of alcohol (HIGH)
Trial: 33565706
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g erythritol
Trial: 33755176
Drug: Preemptive antiviral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preemptive antiviral therapy (PET) with valganciclovir
Trial: 616930567
Drug: HAS combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAS combined therapy with vinorelbine-based chemotherapy
Trial: 34124972
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy for insomnia and pain (CBTi.p., N = 18)
Trial: 32454191
Drug: 3-Dimensional Conformal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-Dimensional Conformal Radiation Therapy (3DCRT)
Trial: 39357788
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Radiation Therapy (IMRT)
Trial: 37222189
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy